Internformat
MARC
LEADER | 00000nmm a2200000 c 4500 | ||
---|---|---|---|
001 | BV048282914 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 220610s2019 |||| o||u| ||||||eng d | ||
020 | |a 3318065854 |q (electronic bk.) |9 3318065854 | ||
020 | |a 9783318065855 |q (electronic bk.) |9 9783318065855 | ||
035 | |a (OCoLC)1308953111 | ||
035 | |a (DE-599)BVBBV048282914 | ||
040 | |a DE-604 |b ger |e rda | ||
041 | 0 | |a eng | |
049 | |a DE-355 | ||
100 | 1 | |a Cornes, Paul |e Verfasser |4 aut | |
245 | 1 | 0 | |a Biosimilares |c Paul Cornes y David Bennett |
264 | 1 | |a Abingdon, Oxford |b S. Karger |c 2019 | |
300 | |a 1 Online-Ressource | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
650 | 4 | |a Biological Factors | |
650 | 4 | |a Biotechnologie pharmaceutique | |
650 | 7 | |a Biotechnologie pharmaceutique |2 Industrie | |
650 | 7 | |a Médicaments |2 Dénomination commune | |
650 | 7 | |a Médicaments |2 Politique gouvernementale | |
650 | 4 | |a Produits biologiques | |
650 | 4 | |a Biological products | |
650 | 7 | |a Drugs |2 Generic substitution | |
650 | 4 | |a Pharmaceutical biotechnology industry | |
650 | 4 | |a Pharmaceutical biotechnology | |
650 | 4 | |a Pharmaceutical policy | |
650 | 4 | |a Biological products | |
650 | 4 | |a Drugs |x Generic substitution | |
650 | 4 | |a Pharmaceutical biotechnology industry | |
650 | 4 | |a Pharmaceutical biotechnology | |
650 | 4 | |a Pharmaceutical policy | |
653 | 6 | |a Electronic books | |
700 | 1 | |a Bennett, David |e author |4 oth | |
856 | 4 | 0 | |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2294383 |x Verlag |z kostenfrei |3 Volltext |
912 | |a ZDB-4-EOAC | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-033663080 |
Datensatz im Suchindex
_version_ | 1804184109132546048 |
---|---|
adam_txt | |
any_adam_object | |
any_adam_object_boolean | |
author | Cornes, Paul Bennett, David |
author_facet | Cornes, Paul Bennett, David |
author_role | aut aut |
author_sort | Cornes, Paul |
author_variant | p c pc d b db |
building | Verbundindex |
bvnumber | BV048282914 |
collection | ZDB-4-EOAC |
ctrlnum | (OCoLC)1308953111 (DE-599)BVBBV048282914 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01729nmm a2200505 c 4500</leader><controlfield tag="001">BV048282914</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">220610s2019 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3318065854</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">3318065854</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783318065855</subfield><subfield code="q">(electronic bk.)</subfield><subfield code="9">9783318065855</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1308953111</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV048282914</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Cornes, Paul</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Biosimilares</subfield><subfield code="c">Paul Cornes y David Bennett</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Abingdon, Oxford</subfield><subfield code="b">S. Karger</subfield><subfield code="c">2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological Factors</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biotechnologie pharmaceutique</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biotechnologie pharmaceutique</subfield><subfield code="2">Industrie</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Médicaments</subfield><subfield code="2">Dénomination commune</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Médicaments</subfield><subfield code="2">Politique gouvernementale</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Produits biologiques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological products</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Drugs</subfield><subfield code="2">Generic substitution</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological products</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Generic substitution</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology industry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical biotechnology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical policy</subfield></datafield><datafield tag="653" ind1=" " ind2="6"><subfield code="a">Electronic books</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bennett, David</subfield><subfield code="e">author</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2294383</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EOAC</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-033663080</subfield></datafield></record></collection> |
id | DE-604.BV048282914 |
illustrated | Not Illustrated |
index_date | 2024-07-03T20:00:58Z |
indexdate | 2024-07-10T09:34:06Z |
institution | BVB |
isbn | 3318065854 9783318065855 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-033663080 |
oclc_num | 1308953111 |
open_access_boolean | 1 |
owner | DE-355 DE-BY-UBR |
owner_facet | DE-355 DE-BY-UBR |
physical | 1 Online-Ressource |
psigel | ZDB-4-EOAC |
publishDate | 2019 |
publishDateSearch | 2019 |
publishDateSort | 2019 |
publisher | S. Karger |
record_format | marc |
spelling | Cornes, Paul Verfasser aut Biosimilares Paul Cornes y David Bennett Abingdon, Oxford S. Karger 2019 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Biological Factors Biotechnologie pharmaceutique Biotechnologie pharmaceutique Industrie Médicaments Dénomination commune Médicaments Politique gouvernementale Produits biologiques Biological products Drugs Generic substitution Pharmaceutical biotechnology industry Pharmaceutical biotechnology Pharmaceutical policy Electronic books Bennett, David author oth https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2294383 Verlag kostenfrei Volltext |
spellingShingle | Cornes, Paul Bennett, David Biosimilares Biological Factors Biotechnologie pharmaceutique Biotechnologie pharmaceutique Industrie Médicaments Dénomination commune Médicaments Politique gouvernementale Produits biologiques Biological products Drugs Generic substitution Pharmaceutical biotechnology industry Pharmaceutical biotechnology Pharmaceutical policy |
title | Biosimilares |
title_auth | Biosimilares |
title_exact_search | Biosimilares |
title_exact_search_txtP | Biosimilares |
title_full | Biosimilares Paul Cornes y David Bennett |
title_fullStr | Biosimilares Paul Cornes y David Bennett |
title_full_unstemmed | Biosimilares Paul Cornes y David Bennett |
title_short | Biosimilares |
title_sort | biosimilares |
topic | Biological Factors Biotechnologie pharmaceutique Biotechnologie pharmaceutique Industrie Médicaments Dénomination commune Médicaments Politique gouvernementale Produits biologiques Biological products Drugs Generic substitution Pharmaceutical biotechnology industry Pharmaceutical biotechnology Pharmaceutical policy |
topic_facet | Biological Factors Biotechnologie pharmaceutique Médicaments Produits biologiques Biological products Drugs Pharmaceutical biotechnology industry Pharmaceutical biotechnology Pharmaceutical policy Drugs Generic substitution |
url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=2294383 |
work_keys_str_mv | AT cornespaul biosimilares AT bennettdavid biosimilares |